申请人:Merck Sharp & Dohme Ltd.
公开号:US06355798B1
公开(公告)日:2002-03-12
1,2,4-triazolo[4,3-b]pyridazine derivatives, possessing an optionally substituted cycloalkyl, phenyl or heteroaryl substituent as the 3-position and an amino moiety at the 6-position, are selective ligands for GABAA receptors, in particular having high affinity for the &agr;2 and/or &agr;3 subunit thereof, are useful in the treatment of anxiety and convulsions.
具有可选取代环烷基、苯基或杂环芳基取代基作为3位和氨基基团作为6位的1,2,4-三唑并[4,3-b]吡啶衍生物,是GABAA受体的选择性配体,特别是具有高亲和力的&agr;2和/或&agr;3亚基,可用于治疗焦虑和惊厥。